🇺🇸 FDA
Patent

US 8859736

Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 8859736 (Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof) held by The Board of Regents of the University of Oklahoma expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61K9/0048